Phibro Animal Health | PAHC - Creditori Commerciali





Creditori Commerciali Cambiamento Data
Align Technology USD 109.84M 13.88M 2026-06
ANI Pharmaceuticals USD 69.69M 7.11M 2026-03
Aurora Cannabis CAD 9.31M 58.72M 2026-03
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Canopy Growth CAD 34.82M 14.85M 2026-03
Corcept Therapeutics USD 14.91M 18.4M 2026-06
Eli Lilly USD 5.03B 350M 2026-03
Henry Schein USD 1.04B 111M 2026-03
Idexx Laboratories USD 129.97M 19.57M 2026-03
Knight Therapeutics CAD 125.76M 7.63M 2025-12
Merck USD 3.86B 541M 2026-03
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Pacira USD 14.01M 1.14M 2026-03
Phibro Animal Health USD 129.64M 3.65M 2026-03
Prestige Brands USD 22.79M 20.15M 2026-03
Supernus Pharmaceuticals USD 10.17M 97.63M 2026-03
Zoetis USD 507M 20M 2026-03